Provided By PR Newswire
Last update: Mar 3, 2025
NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read more at prnewswire.com94.65
+0.65 (+0.69%)
Find more stocks in the Stock Screener
Discover MERCK & CO. INC., an undervalued stock. NYSE:MRK showcases solid financial health and profitability while maintaining an appealing valuation.
Why MERCK & CO. INC. (NYSE:MRK) provides a good dividend, while having solid fundamentals.